LFG
VERA icon

Larson Financial Group’s Vera Therapeutics VERA Stock Holding History

Larson Financial Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93K Sell
45
-61
-58% -$2.27K ﹤0.01% 3132
2026
Q1 		$4.26K Buy
106
+48
+83% +$2.07K ﹤0.01% 2673
2025
Q4 		$2.94K Buy
58
+4
+7% +$142 ﹤0.01% 2676
2025
Q3 		$1.57K Buy
+54
New +$1.25K ﹤0.01% 2794

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Larson Financial Group's VERA Position: Q2 2026 in Review

Larson Financial Group reduced its Vera Therapeutics (VERA) stake by 58% in Q2 2026, selling an estimated $2.27K and leaving 45 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3132.

Larson Financial Group first reported a position in VERA in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.26K in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Larson Financial Group held 45 shares of Vera Therapeutics worth $1.93K as of Q2 2026.
  • Larson Financial Group sold 61 Vera Therapeutics shares in Q2 2026, an estimated $2.27K.
  • Vera Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3132 holding.
  • Larson Financial Group first reported a position in Vera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Vera Therapeutics position peaked at $4.26K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.